Abstract
In Germany, the first national consensus between six medical scientific associations on evidence-based recommendations for prevention and therapy of retinopathy/maculopathy in type 2 diabetes was reached in fall 2006. The recommendations' main sources are the NICE Retinopathy Guideline 2002, and existing German guidelines and reviews of recent scientific evidence. The article gives an overview on authors, sources, and key recommendations of the German National Disease Management Guideline Type 2 Diabetes-Retinopathy/Maculopathy 2006 (www.diabetes.versorgungsleitlinien.de).
MeSH terms
-
Adult
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Blindness / epidemiology
-
Blindness / etiology
-
Blindness / prevention & control
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / prevention & control
-
Diabetes Mellitus, Type 2 / therapy*
-
Diabetic Retinopathy / blood
-
Diabetic Retinopathy / complications
-
Diabetic Retinopathy / diagnosis
-
Diabetic Retinopathy / etiology
-
Diabetic Retinopathy / prevention & control
-
Diabetic Retinopathy / therapy*
-
Disease Management*
-
Disease Progression
-
Early Diagnosis
-
Exercise
-
Family Practice
-
Germany
-
Glycated Hemoglobin / analysis
-
Humans
-
Internal Medicine
-
Life Style
-
Macular Degeneration / etiology
-
Macular Degeneration / prevention & control
-
Macular Degeneration / therapy*
-
Middle Aged
-
Ophthalmology
-
Practice Guidelines as Topic
-
Prognosis
-
Risk Factors
-
Societies, Medical
-
Time Factors
-
Weight Loss